Search Results 1511-1520 of 16361 for alt

1. Niraparib + TSR042 In BRCA Mutated Breast Cancer - Mayo Clinic

   - AST (SGOT) and ALT (SGPT) ≤ 2.5 × institutional ULN - Serum or plasma creatinine ≤ 1.5 × institutional ULN, OR calculated creatinine clearance > 50 mL ...

2. Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma - Mayo Clinic

   Alanine aminotransferase (ALT) ≤ 2.5 x ULN (unless has Gilbert's disease)(performed within 7 days prior to day 1 of protocol therapy unless otherwise stated).

3. Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations - Mayo Clinic

   Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) ≤ 10 x upper limit of normal (ULN) for age. Adequate cardiac function defined ...

4. Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome - Mayo Clinic

   ALT > 3 × upper limit of normal (ULN) or total bilirubin > 2 × ULN at time of randomization. Subjects with a known or suspected history of Gilbert's ...

5. Pembrolizumab With or Without Anetumab Ravtansine in Treating Patients With Mesothelin-Positive Pleural Mesothelioma - Mayo Clinic

   AST(SGOT)/ALT(SGPT) ≤ 2.5 × institutional upper limit of normal (ULN). creatinine Within normal institutional limits OR creatinine clearance ≥ 60 mL/min ...

6. Radiation Therapy with Durvalumab or Cetuximab to Treat Patients with Locoregionally Advanced Head and Neck Cancer who Cannot Take Cisplatin - Mayo Clinic

   Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) ≤ 2.5 times institutional upper limit of normal (within 14 days prior to step 1 registration); ...

7. SPI-62 as a Treatment for Adrenocorticotropic Hormone-dependent Cushing’s Syndrome - Mayo Clinic

   ... ALT or AST > 3 × ULN. Medically significant cardiovascular or ECG abnormalities: This includes subjects with recent (< 1 year) myocardial infarction or ...

8. Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal Cancer - Mayo Clinic

   involvement of their cancer) (obtained =< 7 days prior to randomization). - Alanine aminotransferase (ALT) =< 2.5 x ULN (=< 5 x ULN for subjects with liver

9. A Study to Evaluate M7824 with Concurrent Chemoradiation (cCRT) in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) - Mayo Clinic

   ... (ALT) level ≤3.0 × ULN and alkaline phosphatase ≤ 2.5 ULN;; Adequate renal function defined by creatine ≤ 1.5 × ULN or calculated creatinine clearance ...

10. A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302) - Mayo Clinic

    Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels 3.0 × the upper limit of normal (ULN). Total bilirubin level ≥ 1.5 times the ULN ...